A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
Clinical trial NCT06123663 · COMPLETED
Trial details
- NCT number
- NCT06123663
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2024-01-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.